Our
Collaborations

Immatics harnesses a suite of technology platforms matched with advanced biologic understanding to identify antigens which are highly specific to cancer cells, thereby delivering true targets: distinct molecular barcodes that identify tumor cells and that are not present on healthy cells. The resulting target resource gives the Immatics team a drug discovery advantage for the company’s own proprietary pipeline and for collaborations with world-leading industry partners.

Immatics expects to grow utilizing the knowledge and experience gained from the partnered programs to improve the development pathways for its proprietary programs.

GSK – Research Collaboration

GSK and Immatics Enter Strategic Collaboration to Develop Novel Adoptive Cell Therapies Targeting Multiple Cancer Indications (Focus on development of Adoptive Cell Therapies)

Bristol-Myers Squibb – Research collaboration

Immatics and Bristol-Myers Squibb Company, Enter Strategic Collaboration to Develop Novel Adoptive Cell Therapies (Focus on development of Adoptive Cell Therapies)

Genmab – Research collaboration

Immatics Enters into a Strategic Partnership with Genmab to Develop Next Generation Bispecific Cancer Immunotherapies (Focus on development of Bispecifics)

Amgen – Research collaboration

Amgen and Immatics Enter Strategic Collaboration to Develop Novel Bispecific Cancer Immunotherapies (Focus on development of Bispecifics)

MDACC – Strategic partnership

Immatics and MD Anderson Announce Launch of Immatics US, Inc., to Develop Multiple T-cell and TCR-based Adoptive Cellular Therapies (Focus on clinical ACT development)

MorphoSys – Strategic Collaboration

MorphoSys and Immatics Biotechnologies Enter Strategic Alliance in Immuno-oncology (Focus on mAb development)

Contact us about
Partnering Opportunities

Business Development

E-Mail: partnering@immatics.com
Immatics Biotechnologies GmbH
Business Development Group
Machtlfinger Str. 11
81379 München
Germany

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close